VYNE Therapeutics Inc.
VYNE | NASDAQ
$28.56
$0.00 (0.00%)
Nov 2, 2026, 10:41 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -18.71M | -21.46M | -26.48M | -33.67M | -38.55M | -42.2M | -39.83M | -34M | -27.91M | -28.55M | -27.91M | -31.67M | -34.85M | -33.29M | -23.01M | -24.63M | -29.65M | -31.86M | -57.08M | -68.69M | -79.13M | -235.89M |
Depreciation & Amortization | 2K | 5K | 23K | 18K | 12K | 6K | n/a | n/a | n/a | n/a | n/a | -155K | 16K | 28K | 72K | 253K | 110K | 126K | 109K | 170K | 209K | 275K |
Stock-Based Compensation | 1.93M | 2.02M | 2.31M | 2.48M | 2.73M | 3.08M | 3.3M | 3.31M | 3.44M | 3.43M | 3.31M | 3.66M | 3.97M | 4.26M | 4.3M | 4.56M | 5.79M | 6.53M | 8.08M | 9.7M | 9.92M | 18.78M |
Other Working Capital | -25K | -62K | -99K | -122K | -119K | -117K | -114K | 22K | 552K | 324K | -422K | 1.99M | 1.45M | 515K | -8.44M | -12.71M | -12.34M | -11.39M | -1.26M | 12.55M | 13.81M | -702K |
Other Non-Cash Items | -640K | -472K | -778K | -1.23M | -1.58M | -1.99M | -2.44M | -2.15M | -1.3M | 174K | 1.8M | 2.33M | 2.99M | 2.18M | -11.67M | -10.65M | -13.4M | -20.86M | -8.04M | -9.25M | -7.4M | 138.61M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 93K | 93K | 93K | 93K | 2.1M | 2.1M | 2.1M |
Change in Working Capital | 470K | -5.86M | -8.19M | -5.96M | -2.38M | 3.64M | 5M | 2.73M | -120K | -1.17M | 60K | 4.34M | 4.72M | 4.15M | 3.21M | -2.86M | -5.37M | -2.58M | 4.78M | -1.45M | -1.62M | -21.31M |
Operating Cash Flow | -16.93M | -25.74M | -33.12M | -38.36M | -39.77M | -37.45M | -33.97M | -30.11M | -26.75M | -27.84M | -25.34M | -24.08M | -26.05M | -24.7M | -28.26M | -34.41M | -44.82M | -52.86M | -56.37M | -71.72M | -77.82M | -97.42M |
Capital Expenditures | n/a | n/a | n/a | -117K | -117K | -117K | -117K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113K | -113K | -184K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 4.07M | 3.98M | 3.98M | 14.73M | 15.67M | 15.75M | 15.75M | n/a | -38.64M | -38.64M | -38.64M |
Purchase of Investments | -7.59M | -17.16M | -30.93M | -40.19M | -61.81M | -59.12M | -60.52M | -50.47M | -22.05M | -15.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38.64M | 38.64M | 38.64M |
Sales Maturities Of Investments | 25.45M | 39.4M | 68.3M | 81.95M | 94.35M | 106M | 84M | 61.1M | 37.5M | 11.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.03M | 1.03M | 3.03M | 3.03M | 23.2M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -62.35M | -62.35M | -62.35M | -62.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 113K | 113K | 113K |
Investing Cash Flow | 17.86M | 22.24M | 37.37M | 41.65M | 32.42M | 46.77M | 23.37M | -51.73M | -46.9M | -65.92M | -57.35M | 4.07M | 3.98M | 3.98M | 14.73M | 15.67M | 15.75M | 16.78M | 1.03M | 3.03M | 3.03M | 23.13M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36.43M | -36.43M | -36.43M | -36.43M | n/a | n/a |
Common Stock Repurchased | -22K | -56K | -56K | -41K | -34K | n/a | n/a | n/a | n/a | n/a | -360K | -360K | -360K | -360K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -14K | n/a | n/a | -132K | -134K | -136K | -141K | -11K | -9K | -7K | -2K | 209K | 209K | 234K | 209K | -9K | -9K | -34K | 367K | 363K | 445K | 405K |
Financial Cash Flow | -51K | -71K | -143K | -260K | -255K | -223K | -141K | 82.65M | 82.61M | 82.61M | 82.39M | -61K | -40K | -96K | 1.65M | 1.41M | -32.13M | -32.19M | 39.78M | 47.8M | 81.44M | 135.17M |
Net Cash Flow | 878K | -3.58M | 4.1M | 3.03M | -7.61M | 9.09M | -10.75M | 817K | 8.95M | -11.16M | -301K | -20.08M | -22.11M | -20.82M | -11.88M | -17.33M | -61.2M | -68.27M | -15.56M | -20.9M | 6.65M | 60.92M |
Free Cash Flow | -16.93M | -25.74M | -33.12M | -38.48M | -39.89M | -37.57M | -34.09M | -30.11M | -26.75M | -27.84M | -25.34M | -24.08M | -26.05M | -24.7M | -28.26M | -34.41M | -44.82M | -52.86M | -56.37M | -71.84M | -77.93M | -97.61M |
Adj. Free Cash Flow | -18.86M | -27.76M | -35.43M | -40.95M | -42.62M | -40.65M | -37.39M | -33.42M | -30.2M | -31.28M | -28.65M | -27.74M | -30.03M | -28.96M | -32.56M | -38.97M | -50.62M | -59.39M | -64.45M | -81.54M | -87.85M | -116.39M |
Maintenance CapEx | n/a | n/a | n/a | -116.11K | -116.11K | -116.11K | -116.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -888 | -888 | -888 | -888 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113K | -113K | -184K |
Owner Earnings | -16.93M | -25.74M | -33.12M | -38.48M | -39.89M | -37.57M | -34.09M | -30.11M | -26.75M | -27.84M | -25.34M | -24.08M | -26.05M | -24.7M | -28.26M | -34.41M | -44.82M | -52.86M | -56.37M | -71.72M | -77.82M | -97.42M |
Add to Watchlist
Select watchlists to add or remove VYNE